Macro
Moderna’s Phase III Covid-19 vaccine trial meets primary endpoints
Moderna has announced positive interim results from the Phase III NextCOVE clinical trial, where its next-generation Covid-19 vaccine candidate, mRNA-1283,…
Psychedelic treatments for mental health: Is there substance behind the hype?
Psychedelic treatments have been considered in the treatment of mental health since the 1950s, following Albert Hofmann’s development of lysergic…
AstraZeneca’s Evusheld fails to improve Covid outcomes in Phase III trial
The University of Minnesota’s Center for Infectious Disease Research & Policy (CIDRAP) has reported that AstraZeneca's monoclonal antibody combination drug,…
Osivax kicks off broad spectrum coronavirus vaccine trial
Osivax has kickstarted its Phase I clinical trial (NCT06128382) by vaccinating the first participant with its OVX033 sarbecovirus (coronavirus) vaccine…
Q4 2023 update: environmental sustainability related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that environmental sustainability accounted for 6 pharmaceutical deals announced in Q4…
Q4 2023 update: COVID-19 related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that COVID-19 accounted for 2 pharmaceutical deals announced in Q4 2023,…
Shionogi reports data from Phase III portion of Covid-19 drug trial
Shionogi has announced that ensitrelvir, its oral antiviral Covid-19 drug, has met primary and key secondary endpoints in the Phase…
AIM’s ampligen stumbles in Phase II trial
AIM ImmnunoTech has released topline results from a Phase II trial evaluating its Ampligen (rintatolimod) drug in people with post-Covid…
CSL and Arcturus’ Covid-19 booster found to prolong immunity
CSL and Arcturus Therapeutics have published follow-up analysis from a Phase III clinical trial indicating that ARCT-154, a self-amplifying messenger…
Vaxart’s oral Covid-19 vaccine trial receives BARDA funding
Vaxart has announced a funding boost for its oral Covid-19 vaccine candidate, with the US Biomedical Advanced Research and Development…
